Susquehanna International Group’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Susquehanna International Group’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12,600	Closed	-$31K	–	10923
2018 Q2	$31K	Buy	+12,600	New	+$30.9K	﹤0.01%	9370
2017 Q4	–	Sell	-42,200	Closed	-$133K	–	10436
2017 Q3	$133K	Sell	42,200 -204,900	-83%	-$658K	﹤0.01%	8256
2017 Q2	$993K	Buy	247,100 +42,000	+20%	+$183K	﹤0.01%	5276
2017 Q1	$759K	Buy	+205,100	New	+$644K	﹤0.01%	5710
2015 Q2	–	Sell	-5,030	Closed	-$538K	–	10727
2015 Q1	$538K	Sell	5,030 -830	-14%	-$79.1K	﹤0.01%	6963
2014 Q4	$550K	Sell	5,860 -730	-11%	-$69.6K	﹤0.01%	7032
2014 Q3	$506K	Buy	6,590 +5,050	+328%	+$398K	﹤0.01%	7190
2014 Q2	$138K	Buy	+1,540	New	+$94.4K	﹤0.01%	9290

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

MFGP

Marshall Financial Group (Pennsylvania) Doylestown, Pennsylvania $364M AUM 12.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group's PTX Position: Q2 2018 in Review

Susquehanna International Group sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2018, closing a stake of 15,124 shares — an estimated $37K sold.

Susquehanna International Group first reported a position in PTX in Q2 2014 and held it in 10 quarters. The position peaked at $854K in Q2 2014. 29 funds tracked by Wall St. Rank hold PTX as of Q2 2018.

Susquehanna International Group reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2018 after selling out during the quarter.
Susquehanna International Group sold 15,124 Pernix Therapeutics Holdings, Inc. shares in Q2 2018, an estimated $37K.
Susquehanna International Group first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 10 quarters.
Susquehanna International Group's Pernix Therapeutics Holdings, Inc. position peaked at $854K in Q2 2014.
29 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2018.

Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.